SCHEMBL2560698

SCHEMBL2560698

Cc1cc(O[C@H](C)CCC2CCN(C(=O)OC(C)(C)C)CC2)ccc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 12/20 0.46
KDM4E B2RXH2 3/20 0.44
PKM P14618 1/20 0.44
YAP1 P46937 3/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 2/20 0.42
USP2 O75604 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CRHBP P24387 1/20 0.41
HTT P42858 1/20 0.41
CRHR2 Q13324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2557716 0.90 EED (0.46) GPR119KDM4EPKMYAP1ALDH1A1
SCHEMBL26635590 0.87 GPR119 (0.47) GPR119KDM4EPKMYAP1ALDH1A1
SCHEMBL26636545 0.87 GPR119 (0.47) GPR119KDM4EPKMYAP1ALDH1A1
SCHEMBL26636540 0.87 GPR119 (0.47) GPR119KDM4EPKMYAP1ALDH1A1
SCHEMBL26637294 0.87 GPR119 (0.47) GPR119KDM4EPKMYAP1ALDH1A1
SCHEMBL26635583 0.87 GPR119 (0.47) GPR119KDM4EPKMYAP1ALDH1A1
SCHEMBL1833006 0.85 GPR119 (0.44) GPR119KDM4EPKMALDH1A1MAPT
SCHEMBL1296310 0.84 GPR119 (0.63) GPR119
SCHEMBL1296357 0.80 GPR119 (0.48) GPR119KDM4EKMT2AMEN1ALDH1A1
SCHEMBL7406884 0.80 GPR119 (0.56) GPR119KDM4EKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011128394-A1 3-SUBSTITUTED 5-(PYRROLIDINE-1-CARBONYL) PYRROLIDINE AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2011-10-20 WO disclosed